Friday 6 November 2026 Export SNOA’s income statement to Excel — free account

Sonoma Pharmaceuticals, Inc.

SNOA Healthcare Drug Manufacturers Specialty & Generic

Sonoma Pharmaceuticals, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $19.5 million, up 36.7% from fiscal 2025.

Revenue: +59.6%
EPS: +88.2%
Free cash flow: +69.3%

Quarter to June 2026, against a year earlier

1.12 0.05 +4.67%

Follow SNOA

Alert me

Market cap: $5.1M
P/E: 0.0×
Fwd P/E: −2.0×
Dividend yield: —
F-score: 3/9
Altman Z: −18.52
Beneish M: −1.69
Dividend safety: n/a

Overview

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	0.22	0.18	0.35	0.38
P/FCF ratio Full definition →	0.00	0.00	0.00	0.00
P/Operating CF Full definition →	(7.29)	(6.91)	(8.16)	(10.06)
P/B ratio Full definition →	0.72	1.16	1.82	1.69
Price to Tangible BV Full definition →	0.72	1.16	1.82	1.69
EV/Sales Full definition →	(0.02)	0.07	0.21	0.20
EV/EBITDA Full definition →	0.40	0.00	0.00	0.00
EV/Operating CF Full definition →	0.20	(0.33)	(1.07)	(1.58)
EV/FCF Full definition →	0.19	(0.31)	(1.01)	(1.47)
Quick Ratio Full definition →	1.56	1.02	1.17	1.33
Current Ratio Full definition →	2.99	2.50	2.88	2.89
Net Debt/EBITDA Full definition →	667.25	7.54	3.98	10.08
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	1.34	1.41	1.30	1.23
Operating CF/Net income Full definition →	1.97	0.89	0.93	1.19
Capex/Depreciation Full definition →	(0.06)	(0.88)	(1.38)	(0.28)
Research and Development Expense of Revenue Full definition →	9.32%	9.80%	12.81%	10.26%
Selling, General and Administrative Expense of Revenue Full definition →	31.53%	35.73%	40.72%	33.58%
Intangible Assets out of Total Assets Full definition →	0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →	0.91%	2.43%	0.55%	0.70%
Graham Net Nets Full definition →	1.01	0.34	0.31	0.38
Graham Number Full definition →	0.00	0.00	0.00	0.00
Earnings Yield Full definition →	(99.19%)	(88.73%)	(56.04%)	(56.44%)
Free Cash Flow Yield Full definition →	(56.12%)	(115.00%)	(59.64%)	(36.72%)
Revenue per Share Full definition →	1.67	3.30	2.54	3.40
Operating CF per Share Full definition →	(0.17)	(0.31)	(0.45)	(0.39)
Capex per Share Full definition →	0.00	(0.02)	(0.03)	(0.01)
Free Cash Flow per Share Full definition →	(0.17)	(0.33)	(0.47)	(0.39)
Cash per Share Full definition →	1.39	1.42	1.50	1.84
Shareholders Equity per Share Full definition →	1.71	1.84	2.00	2.30
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	1.71	1.84	2.00	2.30
Free Cash Flow Full definition →	(0.65)	(0.55)	(0.81)	(0.64)
Working Capital Full definition →	10.82	7.27	7.93	8.18
Capital Expenditures Full definition →	0.00	(0.03)	(0.05)	(0.01)
Net Current Asset Value Full definition →	4.76	1.24	1.95	2.43
EV/EBIT Full definition →	0.36	0.00	0.00	0.00
Capex to Sales Full definition →	0.00	0.01	0.01	0.00
Price to Operating Income Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	2.89	2.38	2.39	2.93
Average Payables Full definition →	2.12	1.44	1.52	1.09
Average Inventory Full definition →	3.79	3.28	3.42	3.24
Average Assets Full definition →	16.35	13.83	13.65	13.77
Average Common Equity Full definition →	5.33	3.75	4.15	4.57

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026

Stockrow Weekly